Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTHER OTC:FSPKF
RESEARCH TOOLSreports
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Stock Price & Analysis
40 Followers
FSPKF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.58 - $17.39
Previous Close$15.58
Volume297.00
Average Volume (3M)3.15K
Market Cap
$9.15B
Enterprise Value$9.04B
Total Cash (Recent Filing)$289.90M
Total Debt (Recent Filing)$104.30M
Price to Earnings (P/E)56.2
Beta0.92
Next Earnings
May 22, 2024EPS EstimateN/A
Last Dividend Ex-Date
Dec 04, 2013Dividend Yield1.9%
Share Statistics
EPS (TTM)0.28
Shares Outstanding583,979,696
10 Day Avg. Volume30
30 Day Avg. Volume3,146
Standard Deviation0.11
R-Squared0.14
Alpha0.00332
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$14.31Price Target Upside-8.50% Downside
Rating ConsensusHold
Number of Analyst Covering4
Fisher & Paykel Healthcare Corporation Limited News
PremiumCompany Announcements
Fisher & Paykel Securities Conditions Unmet
PremiumCompany Announcements
Fisher & Paykel Launches Ultra-Light OSA Mask
Options Prices
Currently, No data available
---
Ownership Overview
1.32% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
98.68% Public Companies and
Individual Investors
FSPKF FAQ
What was Fisher & Paykel Healthcare Corporation Limited’s price range in the past 12 months?
Fisher & Paykel Healthcare Corporation Limited lowest stock price was $11.58 and its highest was $17.39 in the past 12 months.
What is Fisher & Paykel Healthcare Corporation Limited’s market cap?
Currently, no data Available
When is Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date?
Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date is May 22, 2024 which is in 28 days.
How were Fisher & Paykel Healthcare Corporation Limited’s earnings last quarter?
Fisher & Paykel Healthcare Corporation Limited released its earnings results on Nov 28, 2023. The company reported $0.113 earnings per share for the quarter, beating the consensus estimate of N/A by $0.113.
Is Fisher & Paykel Healthcare Corporation Limited overvalued?
According to Wall Street analysts Fisher & Paykel Healthcare Corporation Limited’s price is currently Overvalued.
Does Fisher & Paykel Healthcare Corporation Limited pay dividends?
Fisher & Paykel Healthcare Corporation Limited pays a Notavailable dividend of $0.05 which represents an annual dividend yield of 1.9%. See more information on Fisher & Paykel Healthcare Corporation Limited dividends here
What is Fisher & Paykel Healthcare Corporation Limited’s EPS estimate?
Fisher & Paykel Healthcare Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fisher & Paykel Healthcare Corporation Limited have?
Fisher & Paykel Healthcare Corporation Limited has 583,979,700 shares outstanding.
What happened to Fisher & Paykel Healthcare Corporation Limited’s price movement after its last earnings report?
Fisher & Paykel Healthcare Corporation Limited reported an EPS of $0.113 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.242%.
Which hedge fund is a major shareholder of Fisher & Paykel Healthcare Corporation Limited?
Currently, no hedge funds are holding shares in FSPKF
---
Fisher & Paykel Healthcare Corporation Limited Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.31 (-8.50% Downside)
$14.31 (-8.50% Downside)
Blogger Sentiment
Bullish
FSPKF Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $48.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.96%
12-Months-Change
Fundamentals
Return on Equity
17.01%
Trailing 12-Months
Asset Growth
21.20%
Trailing 12-Months
Company Description
Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: The New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.
---
FSPKF Company Deck
---
FSPKF Earnings Call
Q2 2023
0:00 / 0:00
---
FSPKF Stock 12 Months Forecast
Average Price Target
$14.31
▼(-8.50% Downside)
Technical Analysis
Best Analysts Covering FSPKF
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
+0.83%
reiterated a sell rating last month
Copying Adrian Allbon's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +0.83% per trade.
---